Project Grant HT94252310817
Award Date
9/1/23
Completion Date
8/31/26
Dollars Obligated
$1.7M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
This Project Grant award from the Defense Health Agency provides $1,077,570.00 to New York University (NYU) to develop a state-of-the-art microbur-driven non-absorbable epithelial SERT antagonist to treat anxiety and depression in military members and the general public. The award is funded under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public through...
The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, received a $567,654 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This funding supports spatial profiling of early, osimertinib-resistant brain lesions in EGFR-mutant lung cancer models over the 2-year period from July 1, 2023 to June 30, 2025. Through this grant, Columbia University will conduct biomedical...
The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, was awarded a $656,272 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research aimed at optimizing PD-1 immunotherapy through increased T cell regeneration and reduced antigen load. This 2-year project will be conducted in New York, NY from September 1, 2023 to August 31, 2025. The Military Medical...
The Defense Health Agency awarded a $658,000 Project Grant to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "OVERCOMING IMMUNOTHERAPY RESISTANCE IN CCNE1-AMPLIFIED STOMACH CANCER", is intended to support research to improve treatment options for stomach cancer patients. The 3-year project will run from May 1, 2024 to April 30,...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,142,336.00 in funding to The Trustees of Columbia University in the City of New York to conduct research on predicting and understanding the side effects of androgen deprivation therapy in veterans with prostate cancer undergoing long-term treatment. The three-year project aims to apply data science approaches to gain insights that can...
This Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $1,480,500.00 to The Trustees of Columbia University in the City of New York to develop a peptide-based drug delivery system targeting metastatic prostate cancer. The project will run from September 15, 2023 to September 14, 2026. The Department of Defense grant supports basic, applied, and advanced biomedical research with the goal of transforming healthcare for...
The Trustees of Columbia University in New York City will receive $708,000 through a three-year Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant will fund research into IDH mutations and their effects on chromatin and solid tumor differentiation metabolism from July 1, 2021 to June 30, 2024.
Through this award, Columbia University researchers will investigate how metabolism impacts chromatin and tumor differentiation in...
This $1,493,233 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting gene therapy research in a nonhuman primate model of cognitive defects in Parkinson's disease. The award, which runs from November 2024 to November 2027, was granted to The Trustees of Columbia University in the City of New York, through its Health Sciences Division. As a leading research institution, Columbia University has extensive...
The Trustees of Columbia University in the City of New York (Columbia University) was awarded a $658,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 targeting inflammatory signals as therapeutic strategies for peripheral T-cell lymphoma. Through this award, Columbia University will investigate medical solutions for lymphoma, a type of cancer...
The Defense Health Agency awarded a $1.687 million Project Grant to the Icahn School of Medicine at Mount Sinai under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of May 1, 2023 to April 30, 2027.
The grant will fund research investigating the role of medial amygdala circuits in mediating the effects of diet on post-traumatic behavioral and metabolic complications. Through basic, applied, and advanced biomedical research, this project aims...